Articles by Johns Hopkins Bloomberg School of Public Health

Experts: Use Antibodies from COVID-19 Survivors as Stopgap Measure to Treat Patients, Protect Health Care Workers

Infusions of antibody-laden blood have been used with reported success in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic

The analysis suggests that about 97.5 percent of people who develop symptoms of SARS-CoV-2 infection will do so within 11.5 days of exposure.